glp-1 agonists with cardiovascular benefit Receptor for the Reduction of Atherosclerotic Risk in Patients Type 2 Diabetes Glucagon-like peptide 1 receptor agonists:

These pharmaceutical drugs work by directly mimicking GLP-1 at therapeutic concentrations and are approved for specific medical indications

Bariatric surgery was associated with greater weight loss, but GLP-1 RA therapy was associated with better outcomes

And give your body the patience it needs to adapt to a fundamentally different metabolic environment

N Engl J Med 389(6):514526 Rosenstock J, Frias J, Jastreboff AM, Du Y, Lou J, Gurbuz S et al (2023) Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA

1.5%, respectively)

With the popularity of GLP-1 agonists on the rise, medications like Ozempic or Wegovy are becoming more and more common in people trying to lose weight